Delivery Order SPE2DB22D3019-SPE2DB25FK4FS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency awarded a $2,111.64 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Journavx 50 mg tablets (100-count unit dose packaging). This firm fixed-price contract, which is not set-aside and is competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,269.06 to AmerisourceBergen Drug Corp for JOURNAVX 50 MG tablets (30-count supply), with an ultimate completion date of September 17, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,561.55. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,518.12 to AmerisourceBergen Drug Corp for Journavx 50 mg tablets (30-count packaging) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 10 mg medication. This competitively awarded, non-set-aside contract carries a ceiling value of $36,770.17 and is scheduled for completion by September 11, 2025. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...
- This delivery order, valued at $15,027.64, was awarded on July 28, 2025, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is non-competitive and represents a child award under a larger indefinite delivery contract vehicle with the Defense Logistics Agency's Medical Supply Chain, part of the Department of Defense. AmerisourceBergen Drug Corp will perform at its corporate office location in Conshohocken, PA, delivering...
- This delivery order, valued at $142,433.37, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 22, 2025. The contract is executed through the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense responsible for pharmaceutical and medical product distribution to military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,022.44 to AmerisourceBergen Drug Corp on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in...
- AmerisourceBergen Drug Corp has been awarded a delivery order (Contract 4569349301) valued at $3,016.26 by the Defense Logistics Agency Medical Supply Chain. This firm fixed price, non-set-aside delivery order was executed on September 6, 2025, with an ultimate completion date of September 8, 2025. The contractor's place of performance is its corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4FSDelivery Order
This delivery order, valued at $5,998.20, was awarded to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Journavx 50 mg tablets (30-count units) to support federal medical procurement needs. The contract represents a non-competitive, firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The DLA Troop Support Medical contract under which this delivery order was issued enables the company to supply pharmaceutical products supporting global military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This particular delivery order falls within AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition and competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/15/25 |